Adaptimmune Therapeutics plc (MUN:473A)
Germany flag Germany · Delayed Price · Currency is EUR
0.0270
0.00 (0.00%)
At close: Jan 30, 2026

Adaptimmune Therapeutics Market Cap

Adaptimmune Therapeutics has a market cap or net worth of €6.25 million as of January 30, 2026. Its market cap has decreased by -95.86% in one year.

Market Cap
6.25M
Enterprise Value
25.29M
Revenue
55.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.03

Market Cap Chart

Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 6.25M, a decrease of -99.42%. That is a compound annual growth rate of -38.11%.

History

DateMarket Cap% Change
Jan 30, 20266.25M6.43%
Dec 31, 20255.87M-95.59%
Dec 31, 2024133.14M-18.29%
Dec 29, 2023162.94M-27.20%
Dec 30, 2022223.81M-56.55%
Dec 31, 2021515.06M-24.48%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition